CARASENT ASA |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18.75 NOK | +0.27% |
|
+0.27% | +69.53% |
| May. 03 | Carasent Shareholder Group Likely to Reject EG Norge Offer | MT |
| Apr. 29 | Carasent’s Board Rejects EG Norge's Takeover Bid Plans | MT |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2024 * | 270M 25.01M | Sales 2025 * | 320M 29.64M | Capitalization | 1.36B 126M |
|---|---|---|---|---|---|
| Net income 2024 * | -3M -278K | Net income 2025 * | 13M 1.2M | EV / Sales 2024 * | 3.63 x |
| Net cash position 2024 * | 376M 34.83M | Net cash position 2025 * | 315M 29.17M | EV / Sales 2025 * | 3.25 x |
| P/E ratio 2024 * |
-938
x | P/E ratio 2025 * |
98.7
x | Employees | 165 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 68.01% |
More Fundamentals
* Assessed data
More news
Latest transcript on Carasent ASA
More press releases
| 1 day | +0.27% | ||
| 1 week | +0.27% | ||
| Current month | +0.54% | ||
| 1 month | +70.45% | ||
| 3 months | +72.33% | ||
| 6 months | +37.06% | ||
| Current year | +69.53% |
1 week
18.55
19.00
1 month
10.4019.60
Current year
9.8119.60
1 year
9.8119.60
3 years
9.8151.00
5 years
4.8051.00
10 years
2.0051.00
| Managers | Title | Age | Since |
|---|---|---|---|
Daniel Öhman
CEO | Chief Executive Officer | 44 | 22-10-31 |
| Director of Finance/CFO | 34 | 21-07-31 | |
Shane Smith
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 63 | 22-10-18 | |
Camilla Skoog
BRD | Director/Board Member | 51 | 22-04-27 |
Ulrika Sundling
BRD | Director/Board Member | - | 22-04-27 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-14 | 18.75 | +0.27% | 80,564 |
| 24-05-13 | 18.7 | 0.00% | 218,759 |
| 24-05-10 | 18.7 | +0.54% | 40,174 |
| 24-05-08 | 18.6 | -0.53% | 99,426 |
| 24-05-07 | 18.7 | -1.32% | 111,664 |
Real-time Oslo Bors, May 14, 2024 at 10:45 am EDT
More quotes
Carasent ASA is a Norway-based technology Company. The strategy of Carasent is to develop and expand digitalization that helps customers to meet challenges in providing efficient and qualitative health care services. The Company provides its customers with cloud based medical record software solutions and a broad ecosystem of integrated services, in a range of healthcare segments. Carasent focuses on businesses that develop entrepreneurial and e-health solutions. Operating business activities in the Group can be categorized into six different categories; Software as a Service (SaaS), Add-on services, Consulting, License, maintenance and other. All services are delivered to the health care sector.
Sector
IT Services & Consulting
Calendar
2024-07-11
- Q2 2024 Earnings Call
Trading Rating
Investor Rating
ESG Refinitiv
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +69.53% | 125M | |
| -12.53% | 193B | |
| +2.84% | 171B | |
| +2.33% | 154B | |
| +5.38% | 101B | |
| +10.74% | 80B | |
| +29.07% | 77.2B | |
| -7.66% | 70.57B | |
| -19.12% | 53.36B | |
| -9.89% | 42.57B |
- Stock Market
- Equities
- CARA Stock